Table 1.
All Patients | Female | Male | P Value | |
---|---|---|---|---|
Number | 80 | 19 (24) | 61 (76) | |
Age at study (years) | 44 ± 12 | 53 ± 8 | 41 ± 12 | <0.001 |
Height (cm) | 179 ± 8 | 169 ± 7 | 182 ± 6 | <0.001 |
Weight (kg) | 80 ± 13 | 68 ± 13 | 84 ± 11 | <0.001 |
BMI | 25 ± 3 | 24 ± 4 | 25 ± 3 | n.s. |
LVEDD (mm) | 50 ± 5 | 47 ± 5 | 51 ± 4 | 0.004 |
LVEF (%) | 64 ± 6 | 65 ± 7 | 64 ± 6 | n.s. |
Left atrial diameter (mm) | 36 ± 5 | 36 ± 3 | 36 ± 5 | n.s. |
Hypertension | 8 (10) | 3 (16) | 5 (8) | n.s. |
Beta‐blocker in use | 19 (24) | 4 (21) | 15 (25) | n.s. |
Age at first confirmed AF episode | 40 ± 12 | 50 ± 8 | 37 ± 11 | <0.001 |
Age at onset of AF symptoms | 35 ± 13 | 43 ± 13 | 32 ± 12 | 0.006 |
AF episode frequency | ||||
>1/week | 44 (55) | 10 (53) | 34 (56) | n.s. |
1 /week–1/month | 24 (30) | 7 (37) | 17 (28) | n.s |
<1/month | 12 (15) | 2 (10) | 10 (16) | n.s. |
AF episodes lasting >24 hour | 17 (21) | 3 (16) | 14 (23) | n.s. |
Frequent AF triggers | 58 (72) | 15 (79) | 43 (70) | n.s. |
The values represent the number (percentage in parentheses) of study subjects or mean ± SD. Student's t‐test and chi‐square test were used for statistics.
AF = atrial fibrillation; BMI = weight (kg) divided by height (m)2; HR = heart rate; LVEDD = left ventricular end diastolic diameter; LVEF = left ventricular ejection fraction.